The removal of Venezuela from the United States’ list of countries failing to meet international counternarcotics commitments marks a significant shift in Washington’s drug policy focus in Latin America. This change could reshape U.S. interactions with Venezuela, as the country demonstrates progress against drug-trafficking organizations under the leadership of interim President Delcy Rodríguez. Meanwhile, Colombia remains under scrutiny but has the potential to be delisted next year if it improves its efforts against drug trafficking.
President Donald Trump’s administration cited advancements in Venezuela’s actions against drug networks as the reason for its removal from the list, a stark contrast to previous years when the country was criticized for not fulfilling its counternarcotics obligations. This development could pave the way for enhanced cooperation and engagement between the U.S. and Venezuela in combating drug-related activities.
Colombia, on the other hand, continues to be classified as a country that has not made substantial progress in meeting international counternarcotics objectives. The White House has identified Colombia, along with three other nations, as failing demonstrably over the past year. President Trump indicated that Colombia could be removed from this list if it shows greater progress in addressing coca cultivation, cocaine production, and the broader drug-trafficking infrastructure.
Colombian officials have expressed their commitment to tackling every aspect of the drug trade, including targeting illicit crops, drug production facilities, trafficking routes, financial networks, and the organizations that sustain these operations. This comprehensive approach could potentially lead to Colombia’s removal from the U.S. list, provided measurable progress is achieved in the coming months.
These decisions underscore the United States’ ongoing focus on strengthening counternarcotics collaboration with Latin American nations. Both Venezuela and Colombia remain critical players in the global fight against drug trafficking, designated as major drug-transit or illicit drug-producing countries for fiscal year 2027. However, Venezuela’s recent declassification signals a potential shift in how the U.S. navigates its counternarcotics strategy in the region.